Lovisa returns to pre-COVID levels on European acquisition

On the back of a European acquisition, Jewellery retailer Lovisa (ASX: LOV) has seen its shares bounce back to levels not seen since the COVID-19 pandemic slamm

N-CSR

Events Archive

Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine

ACP - Relations - Explaining apparent particle shrinkage related

Frontiers New insights into maladaptive vascular responses to

U.S. Health Care from a Global Perspective, 2022

Frontiers New insights into maladaptive vascular responses to

Economic Bulletin Issue 2, 2021

Lovisa plans European expansion after exiting Spanish market

Lovisa returns to pre-COVID levels on European acquisition

The gut virome: A new microbiome component in health and disease

COVID-19 lockdown reveals tourists as seabird guardians

Part 3: Adult Basic and Advanced Life Support